uuid stringlengths 4 8 | template_uuid stringclasses 40
values | question stringlengths 13 193 | answer stringlengths 29 2.2k | benchmark_query stringlengths 133 622 | execution_results stringlengths 2 1.14M | query_type stringclasses 2
values | sql_category stringclasses 26
values | bio_category stringclasses 14
values |
|---|---|---|---|---|---|---|---|---|
Q15.629 | Q15 | When was Rofecoxib approved by the FDA? | The drug Rofecoxib was first FDA approved for use in 1999. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%rofecoxib%" OR LOWER(tradeNames_string) LIKE "%rofecoxib%" OR LOWER(drugSynonyms_string) LIKE "%rofecoxib%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_3942', 'drugName': 'Rofecoxib', 'tradeNames_string': 'Vioxx', 'drugSynonyms_string': 'M01AH02, MK-0966, MK-966, MK0966, NSC-720256, NSC-758705, Rofecoxib, TRM-201, TRM201', 'yearOfFirstApproval': 1999, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.1170 | Q15 | When was Eliglustat Tartrate approved by the FDA? | The drug Eliglustat Tartrate was first FDA approved for use in 2014. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%eliglustat tartrate%" OR LOWER(tradeNames_string) LIKE "%eliglustat tartrate%" OR LOWER(drugSynonyms_string) LIKE "%eliglustat tartrate%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_5337', 'drugName': 'Eliglustat Tartrate', 'tradeNames_string': 'Cerdelga', 'drugSynonyms_string': 'Eliglustat hemitartrate, Eliglustat tartrate, GENZ 112638, GENZ-112638', 'yearOfFirstApproval': 2014, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.1254 | Q15 | When was Ebastine approved by the FDA? | The drug Ebastine has not been approved by the FDA. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%ebastine%" OR LOWER(tradeNames_string) LIKE "%ebastine%" OR LOWER(drugSynonyms_string) LIKE "%ebastine%") AND drugIsApproved = True
LIMIT 100 | [] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.230 | Q15 | When was Niraparib approved by the FDA? | The drug Niraparib was first FDA approved for use in 2017. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%niraparib%" OR LOWER(tradeNames_string) LIKE "%niraparib%" OR LOWER(drugSynonyms_string) LIKE "%niraparib%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_4882', 'drugName': 'Niraparib Tosylate', 'tradeNames_string': 'Zejula', 'drugSynonyms_string': 'MK-4827-TOSYLATE, Niraparib tosylate, Niraparib tosylate anhydrous, Niraparib tosylate monohydrate', 'yearOfFirstApproval': 2017, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_4883', 'drugName': 'Niraparib Tosylate', 'tradeNames_string': 'Zejula', 'drugSynonyms_string': 'MK-4827-TOSYLATE, Niraparib tosylate, Niraparib tosylate anhydrous, Niraparib tosylate monohydrate', 'yearOfFirstApproval': 2017, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_4162', 'drugName': 'Niraparib', 'tradeNames_string': 'Zejula', 'drugSynonyms_string': 'JNJ-64091742, MK-4827, MK4827, Niraparib, ZL-2306', 'yearOfFirstApproval': 2017, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_4163', 'drugName': 'Niraparib', 'tradeNames_string': 'Zejula', 'drugSynonyms_string': 'JNJ-64091742, MK-4827, MK4827, Niraparib, ZL-2306', 'yearOfFirstApproval': 2017, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.1180 | Q15 | When was Hexafluorenium approved by the FDA? | The drug Hexafluorenium was first FDA approved for use in 1982. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%hexafluorenium%" OR LOWER(tradeNames_string) LIKE "%hexafluorenium%" OR LOWER(drugSynonyms_string) LIKE "%hexafluorenium%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_4011', 'drugName': 'Hexafluorenium', 'tradeNames_string': '', 'drugSynonyms_string': 'Hexafluorenium, Hexafluorenium cation, Hexafluorenium ion, Hexafluronium', 'yearOfFirstApproval': 1982, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_4592', 'drugName': 'Hexafluorenium Bromide', 'tradeNames_string': 'Mylaxen', 'drugSynonyms_string': 'Hexafluorenium bromide, Hexaflurone bromide, Hexafluronium bromide, NSC-19477', 'yearOfFirstApproval': 1982, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.1332 | Q15 | When was Eltrombopag Olamine approved by the FDA? | The drug Eltrombopag Olamine was first FDA approved for use in 2008. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%eltrombopag olamine%" OR LOWER(tradeNames_string) LIKE "%eltrombopag olamine%" OR LOWER(drugSynonyms_string) LIKE "%eltrombopag olamine%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_2769', 'drugName': 'Eltrombopag Olamine', 'tradeNames_string': 'Promacta, Promacta kit', 'drugSynonyms_string': 'Eltrombopag (as olamine), Eltrombopag compd with 2-aminoethanol (1:2), Eltrombopag olamine, SB-497115-GR', 'yearOfFirstApproval': 2008, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.1587 | Q15 | When was Alitretinoin approved by the FDA? | The drug Alitretinoin was first FDA approved for use in 1999. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%alitretinoin%" OR LOWER(tradeNames_string) LIKE "%alitretinoin%" OR LOWER(drugSynonyms_string) LIKE "%alitretinoin%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_701', 'drugName': 'Alitretinoin', 'tradeNames_string': 'Panretin, Toctino', 'drugSynonyms_string': '9-cis retinoic acid, 9-cis-retinoic acid, AGN 192013, AGN-192013, ALRT-1057, ALRT1057, Alitretinoin, BAL-4079, LG-100057, LG100057, LGD-1057, LGD1057, NSC-659772, Panretin, Retinoic acid 9-cis-form', 'yearOfFirstApproval': 1999, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.69 | Q15 | When was Brimonidine approved by the FDA? | The drug Brimonidine was first FDA approved for use in 1996. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%brimonidine%" OR LOWER(tradeNames_string) LIKE "%brimonidine%" OR LOWER(drugSynonyms_string) LIKE "%brimonidine%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_4923', 'drugName': 'Brimonidine Tartrate', 'tradeNames_string': 'Alphagan, Alphagan p, Brimonidine tartrate, Brymont, Lumify, Mirvaso, Qoliana', 'drugSynonyms_string': 'AGN 190342-LF, AGN-190342-LF, AGN-190342LF, Brimonidine d-tartrate, Brimonidine tartrate, Bromoxidine tartrate, Cd-07805, OCU-300, OCU300, UK-14304-18, UK-1430418', 'yearOfFirstApproval': 1996, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_5908', 'drugName': 'Brimonidine', 'tradeNames_string': '', 'drugSynonyms_string': 'AGN-190342 FREE BASE, Brimonidine, NSC-318825, UK-14304, UK-1430418 FREE BASE', 'yearOfFirstApproval': 1996, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.25 | Q15 | When was Ly-2606368 approved by the FDA? | The drug Ly-2606368 has not been approved by the FDA. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%ly-2606368%" OR LOWER(tradeNames_string) LIKE "%ly-2606368%" OR LOWER(drugSynonyms_string) LIKE "%ly-2606368%") AND drugIsApproved = True
LIMIT 100 | [] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.147 | Q15 | When was Acetaminophen approved by the FDA? | The drug Acetaminophen was first FDA approved for use in 1968. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%acetaminophen%" OR LOWER(tradeNames_string) LIKE "%acetaminophen%" OR LOWER(drugSynonyms_string) LIKE "%acetaminophen%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_146', 'drugName': 'Acetaminophen', 'tradeNames_string': "Abdine, Acephen, Acetaminophen, Alvedon, Angiers, Calpol, Calpol six plus, Calpol six plus fastmelts, Child lemsip, Cupanol, Dafalgan, Datril, Disprol, Disprol infant, Disprol jnr, Disprol paed, Fennings, Galpamol, Hedex, Infadrops, Infants' feverall, Injectapap, Junior parapaed, Mandanol, Medinol, Medinol for children, Medinol over 6, Medinol under 6, Medised plain, Miradol, Neopap, Ofirmev, Paldesic, Panadol, Panadol actifast, Panadol actifast solb, Panadol advan, Panadol jnr, Panadol oa, Panaleve, Panaleve 6 plus, Paracetamol, Paramin, Parapaed jnr, Parapaed six plus, Paravict, Perfalgan, Phenaphen, Placidex, Rimadol, Salzone, Tixymol, Tramil 500, Tylenol", 'drugSynonyms_string': 'Acetaminophen, Apap, Biocetamol, Doliprane, Efferalgan, N-acetyl-p-aminophenol, NSC-109028, NSC-3991, P-hydroxy-acetanilid, Paracetamol, Paracetamolum, Vermidon', 'yearOfFirstApproval': 1968, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_147', 'drugName': 'Acetaminophen', 'tradeNames_string': "Abdine, Acephen, Acetaminophen, Alvedon, Angiers, Calpol, Calpol six plus, Calpol six plus fastmelts, Child lemsip, Cupanol, Dafalgan, Datril, Disprol, Disprol infant, Disprol jnr, Disprol paed, Fennings, Galpamol, Hedex, Infadrops, Infants' feverall, Injectapap, Junior parapaed, Mandanol, Medinol, Medinol for children, Medinol over 6, Medinol under 6, Medised plain, Miradol, Neopap, Ofirmev, Paldesic, Panadol, Panadol actifast, Panadol actifast solb, Panadol advan, Panadol jnr, Panadol oa, Panaleve, Panaleve 6 plus, Paracetamol, Paramin, Parapaed jnr, Parapaed six plus, Paravict, Perfalgan, Phenaphen, Placidex, Rimadol, Salzone, Tixymol, Tramil 500, Tylenol", 'drugSynonyms_string': 'Acetaminophen, Apap, Biocetamol, Doliprane, Efferalgan, N-acetyl-p-aminophenol, NSC-109028, NSC-3991, P-hydroxy-acetanilid, Paracetamol, Paracetamolum, Vermidon', 'yearOfFirstApproval': 1968, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_148', 'drugName': 'Acetaminophen', 'tradeNames_string': "Abdine, Acephen, Acetaminophen, Alvedon, Angiers, Calpol, Calpol six plus, Calpol six plus fastmelts, Child lemsip, Cupanol, Dafalgan, Datril, Disprol, Disprol infant, Disprol jnr, Disprol paed, Fennings, Galpamol, Hedex, Infadrops, Infants' feverall, Injectapap, Junior parapaed, Mandanol, Medinol, Medinol for children, Medinol over 6, Medinol under 6, Medised plain, Miradol, Neopap, Ofirmev, Paldesic, Panadol, Panadol actifast, Panadol actifast solb, Panadol advan, Panadol jnr, Panadol oa, Panaleve, Panaleve 6 plus, Paracetamol, Paramin, Parapaed jnr, Parapaed six plus, Paravict, Perfalgan, Phenaphen, Placidex, Rimadol, Salzone, Tixymol, Tramil 500, Tylenol", 'drugSynonyms_string': 'Acetaminophen, Apap, Biocetamol, Doliprane, Efferalgan, N-acetyl-p-aminophenol, NSC-109028, NSC-3991, P-hydroxy-acetanilid, Paracetamol, Paracetamolum, Vermidon', 'yearOfFirstApproval': 1968, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.542 | Q15 | When was Anileridine approved by the FDA? | The drug Anileridine was first FDA approved for use in 1982. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%anileridine%" OR LOWER(tradeNames_string) LIKE "%anileridine%" OR LOWER(drugSynonyms_string) LIKE "%anileridine%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_1553', 'drugName': 'Anileridine', 'tradeNames_string': '', 'drugSynonyms_string': 'Adopol, Alidine, Anileridine, Apidol, IDS-NA-012, Leritin, Nipecotan', 'yearOfFirstApproval': 1982, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_1554', 'drugName': 'Anileridine', 'tradeNames_string': '', 'drugSynonyms_string': 'Adopol, Alidine, Anileridine, Apidol, IDS-NA-012, Leritin, Nipecotan', 'yearOfFirstApproval': 1982, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_4594', 'drugName': 'Anileridine Hydrochloride', 'tradeNames_string': 'Leritine', 'drugSynonyms_string': 'Aldine, Anileridine dihydrochloride, Anileridine hcl, Anileridine hydrochloride, Anileridine hydrochloride cii, Apodol, Leritine dihydrochloride', 'yearOfFirstApproval': 1982, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_4595', 'drugName': 'Anileridine Hydrochloride', 'tradeNames_string': 'Leritine', 'drugSynonyms_string': 'Aldine, Anileridine dihydrochloride, Anileridine hcl, Anileridine hydrochloride, Anileridine hydrochloride cii, Apodol, Leritine dihydrochloride', 'yearOfFirstApproval': 1982, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_4938', 'drugName': 'Anileridine Phosphate', 'tradeNames_string': 'Leritine', 'drugSynonyms_string': 'Anileridine phosphate, Leritine phosphate', 'yearOfFirstApproval': 1982, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_4939', 'drugName': 'Anileridine Phosphate', 'tradeNames_string': 'Leritine', 'drugSynonyms_string': 'Anileridine phosphate, Leritine phosphate', 'yearOfFirstApproval': 1982, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.818 | Q15 | When was Asg-5Me approved by the FDA? | The drug Asg-5Me has not been approved by the FDA. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%asg-5me%" OR LOWER(tradeNames_string) LIKE "%asg-5me%" OR LOWER(drugSynonyms_string) LIKE "%asg-5me%") AND drugIsApproved = True
LIMIT 100 | [] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.1120 | Q15 | When was Saralasin Acetate approved by the FDA? | The drug Saralasin Acetate was first FDA approved for use in 1982. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%saralasin acetate%" OR LOWER(tradeNames_string) LIKE "%saralasin acetate%" OR LOWER(drugSynonyms_string) LIKE "%saralasin acetate%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_4566', 'drugName': 'Saralasin Acetate', 'tradeNames_string': 'Sarenin', 'drugSynonyms_string': 'P-113, Saralasin acetate, Saralasin hydrated acetate', 'yearOfFirstApproval': 1982, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.88 | Q15 | When was Pentolinium approved by the FDA? | The drug Pentolinium was first FDA approved for use in 1982. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%pentolinium%" OR LOWER(tradeNames_string) LIKE "%pentolinium%" OR LOWER(drugSynonyms_string) LIKE "%pentolinium%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_4468', 'drugName': 'Pentolinium Tartrate', 'tradeNames_string': 'Ansolysen', 'drugSynonyms_string': 'NSC-759890, Pentolinium tartrate, Pentolonium tartrate, Pentolonum bitartrate', 'yearOfFirstApproval': 1982, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_4982', 'drugName': 'Pentolinium', 'tradeNames_string': '', 'drugSynonyms_string': 'Ansolysen, Pentolinium, Pentolinium cation, Pentolinium ion, Pentolonium', 'yearOfFirstApproval': 1982, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.1183 | Q15 | When was Insulin Aspart approved by the FDA? | The drug Insulin Aspart was first FDA approved for use in 2000. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%insulin aspart%" OR LOWER(tradeNames_string) LIKE "%insulin aspart%" OR LOWER(drugSynonyms_string) LIKE "%insulin aspart%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_4979', 'drugName': 'Insulin Aspart', 'tradeNames_string': 'Fiasp, Fiasp flextouch, Fiasp penfill, Ins novorapid, Novolog, Novolog flexpen, Novolog flextouch, Novolog innolet, Novolog penfill', 'drugSynonyms_string': 'B28-ASP-INSULIN, INA-X14, INSULIN X14, Insulin aspart, Insulin aspart recombinant', 'yearOfFirstApproval': 2000, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_1048', 'drugName': 'Insulin Aspart Protamine Recombinant', 'tradeNames_string': '', 'drugSynonyms_string': 'Insulin aspart protamine recombinant', 'yearOfFirstApproval': 2001, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.1333 | Q15 | When was Modimelanotide approved by the FDA? | The drug Modimelanotide has not been approved by the FDA. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%modimelanotide%" OR LOWER(tradeNames_string) LIKE "%modimelanotide%" OR LOWER(drugSynonyms_string) LIKE "%modimelanotide%") AND drugIsApproved = True
LIMIT 100 | [] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.1806 | Q15 | When was X-82 approved by the FDA? | The drug X-82 has not been approved by the FDA. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%x-82%" OR LOWER(tradeNames_string) LIKE "%x-82%" OR LOWER(drugSynonyms_string) LIKE "%x-82%") AND drugIsApproved = True
LIMIT 100 | [] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.1819 | Q15 | When was Pasireotide Pamoate approved by the FDA? | The drug Pasireotide Pamoate was first FDA approved for use in 2014. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%pasireotide pamoate%" OR LOWER(tradeNames_string) LIKE "%pasireotide pamoate%" OR LOWER(drugSynonyms_string) LIKE "%pasireotide pamoate%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_6120', 'drugName': 'Pasireotide Pamoate', 'tradeNames_string': 'Signifor lar, Signifor lar kit', 'drugSynonyms_string': 'Pasireotide embonate, Pasireotide pamoate', 'yearOfFirstApproval': 2014, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_6121', 'drugName': 'Pasireotide Pamoate', 'tradeNames_string': 'Signifor lar, Signifor lar kit', 'drugSynonyms_string': 'Pasireotide embonate, Pasireotide pamoate', 'yearOfFirstApproval': 2014, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_6122', 'drugName': 'Pasireotide Pamoate', 'tradeNames_string': 'Signifor lar, Signifor lar kit', 'drugSynonyms_string': 'Pasireotide embonate, Pasireotide pamoate', 'yearOfFirstApproval': 2014, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_6123', 'drugName': 'Pasireotide Pamoate', 'tradeNames_string': 'Signifor lar, Signifor lar kit', 'drugSynonyms_string': 'Pasireotide embonate, Pasireotide pamoate', 'yearOfFirstApproval': 2014, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.1374 | Q15 | When was Fluvoxamine Maleate approved by the FDA? | The drug Fluvoxamine Maleate was first FDA approved for use in 1994. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%fluvoxamine maleate%" OR LOWER(tradeNames_string) LIKE "%fluvoxamine maleate%" OR LOWER(drugSynonyms_string) LIKE "%fluvoxamine maleate%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_1759', 'drugName': 'Fluvoxamine Maleate', 'tradeNames_string': 'Faverin 100, Faverin 50, Floxyfral, Fluvoxamine maleate, Luvox, Luvox cr', 'drugSynonyms_string': 'DU-23000, DU23000, Faverin, Fevarin, Fluvoxamine hydrogenmaleate, Fluvoxamine maleate, NSC-759602', 'yearOfFirstApproval': 1994, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.1144 | Q15 | When was Carteolol approved by the FDA? | The drug Carteolol was first FDA approved for use in 1988. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%carteolol%" OR LOWER(tradeNames_string) LIKE "%carteolol%" OR LOWER(drugSynonyms_string) LIKE "%carteolol%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_3354', 'drugName': 'Carteolol', 'tradeNames_string': '', 'drugSynonyms_string': 'Carteolol, Cartrol, Ocupress', 'yearOfFirstApproval': 1988, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_1755', 'drugName': 'Carteolol Hydrochloride', 'tradeNames_string': 'Carteolol hydrochloride, Cartrol, Ocupress, Teoptic', 'drugSynonyms_string': 'ABBOTT-43326, Carteolol hcl, Carteolol hydrochloride, NSC-300906, OPC-1085', 'yearOfFirstApproval': 1988, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.367 | Q15 | When was Nimacimab approved by the FDA? | The drug Nimacimab has not been approved by the FDA. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%nimacimab%" OR LOWER(tradeNames_string) LIKE "%nimacimab%" OR LOWER(drugSynonyms_string) LIKE "%nimacimab%") AND drugIsApproved = True
LIMIT 100 | [] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.1790 | Q15 | When was Propoxyphene Napsylate approved by the FDA? | The drug Propoxyphene Napsylate was first FDA approved for use in 1971. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%propoxyphene napsylate%" OR LOWER(tradeNames_string) LIKE "%propoxyphene napsylate%" OR LOWER(drugSynonyms_string) LIKE "%propoxyphene napsylate%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_303', 'drugName': 'Propoxyphene Napsylate', 'tradeNames_string': 'Darvon-n', 'drugSynonyms_string': 'D-propoxyphene napsylate hydrate, Dextropropoxyphene napsilate, Propoxyphene napsylate, Propoxyphene napsylate cii, Propoxyphene napsylate monohydrate', 'yearOfFirstApproval': 1971, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.1208 | Q15 | When was Halothane approved by the FDA? | The drug Halothane was first FDA approved for use in 1958. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%halothane%" OR LOWER(tradeNames_string) LIKE "%halothane%" OR LOWER(drugSynonyms_string) LIKE "%halothane%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_5037', 'drugName': 'Halothane', 'tradeNames_string': 'Fluothane, Halothane, Rhidialothan', 'drugSynonyms_string': 'FREON 123B1, Halothane, Halothanum, NSC-143490', 'yearOfFirstApproval': 1958, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_5038', 'drugName': 'Halothane', 'tradeNames_string': 'Fluothane, Halothane, Rhidialothan', 'drugSynonyms_string': 'FREON 123B1, Halothane, Halothanum, NSC-143490', 'yearOfFirstApproval': 1958, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_5039', 'drugName': 'Halothane', 'tradeNames_string': 'Fluothane, Halothane, Rhidialothan', 'drugSynonyms_string': 'FREON 123B1, Halothane, Halothanum, NSC-143490', 'yearOfFirstApproval': 1958, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_5040', 'drugName': 'Halothane', 'tradeNames_string': 'Fluothane, Halothane, Rhidialothan', 'drugSynonyms_string': 'FREON 123B1, Halothane, Halothanum, NSC-143490', 'yearOfFirstApproval': 1958, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_5041', 'drugName': 'Halothane', 'tradeNames_string': 'Fluothane, Halothane, Rhidialothan', 'drugSynonyms_string': 'FREON 123B1, Halothane, Halothanum, NSC-143490', 'yearOfFirstApproval': 1958, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_5042', 'drugName': 'Halothane', 'tradeNames_string': 'Fluothane, Halothane, Rhidialothan', 'drugSynonyms_string': 'FREON 123B1, Halothane, Halothanum, NSC-143490', 'yearOfFirstApproval': 1958, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_5043', 'drugName': 'Halothane', 'tradeNames_string': 'Fluothane, Halothane, Rhidialothan', 'drugSynonyms_string': 'FREON 123B1, Halothane, Halothanum, NSC-143490', 'yearOfFirstApproval': 1958, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.1035 | Q15 | When was Treprostinil approved by the FDA? | The drug Treprostinil was first FDA approved for use in 2002. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%treprostinil%" OR LOWER(tradeNames_string) LIKE "%treprostinil%" OR LOWER(drugSynonyms_string) LIKE "%treprostinil%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_1758', 'drugName': 'Treprostinil', 'tradeNames_string': 'Remodulin, Tyvaso, Tyvaso dpi', 'drugSynonyms_string': '15-AU-81, 15AU81, L-606, LRX -15, LRX-15, Rumodolin, Treprostinil, Tresprostinil, UT-15, Uniprost', 'yearOfFirstApproval': 2002, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_2433', 'drugName': 'Treprostinil Diolamine', 'tradeNames_string': 'Orenitram, Ut-15c', 'drugSynonyms_string': 'Treprostinil diethanolamine, Treprostinil diolamin, Treprostinil diolamine, UT-15C', 'yearOfFirstApproval': 2013, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.1039 | Q15 | When was Cinaciguat approved by the FDA? | The drug Cinaciguat has not been approved by the FDA. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%cinaciguat%" OR LOWER(tradeNames_string) LIKE "%cinaciguat%" OR LOWER(drugSynonyms_string) LIKE "%cinaciguat%") AND drugIsApproved = True
LIMIT 100 | [] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.1761 | Q15 | When was Timolol Maleate approved by the FDA? | The drug Timolol Maleate was first FDA approved for use in 1978. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%timolol maleate%" OR LOWER(tradeNames_string) LIKE "%timolol maleate%" OR LOWER(drugSynonyms_string) LIKE "%timolol maleate%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_760', 'drugName': 'Timolol Maleate', 'tradeNames_string': 'Blocadren, Istalol, Timolol maleate, Timoptic, Timoptic Xe, Timoptic in ocudose, Timoptic-xe', 'drugSynonyms_string': 'Aquanil, NSC-757351, Ophtamolol, Timolol (as maleate), Timolol hydrogen maleate salt, Timolol maleate, Timolol maleate, s-enantiomer, Timololi maleas, WP-934', 'yearOfFirstApproval': 1978, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_761', 'drugName': 'Timolol Maleate', 'tradeNames_string': 'Blocadren, Istalol, Timolol maleate, Timoptic, Timoptic Xe, Timoptic in ocudose, Timoptic-xe', 'drugSynonyms_string': 'Aquanil, NSC-757351, Ophtamolol, Timolol (as maleate), Timolol hydrogen maleate salt, Timolol maleate, Timolol maleate, s-enantiomer, Timololi maleas, WP-934', 'yearOfFirstApproval': 1978, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.1357 | Q15 | When was Mecamylamine Hydrochloride approved by the FDA? | The drug Mecamylamine Hydrochloride was first FDA approved for use in 1956. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%mecamylamine hydrochloride%" OR LOWER(tradeNames_string) LIKE "%mecamylamine hydrochloride%" OR LOWER(drugSynonyms_string) LIKE "%mecamylamine hydrochloride%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_1272', 'drugName': 'Mecamylamine Hydrochloride', 'tradeNames_string': 'Inversine, Mecamylamine hydrochloride', 'drugSynonyms_string': 'Mecamylamine chloride, Mecamylamine hcl, Mecamylamine hydrochloride, NSC-757086', 'yearOfFirstApproval': 1956, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.1875 | Q15 | When was Rimonabant approved by the FDA? | The drug Rimonabant was first FDA approved for use in 2006. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%rimonabant%" OR LOWER(tradeNames_string) LIKE "%rimonabant%" OR LOWER(drugSynonyms_string) LIKE "%rimonabant%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_3909', 'drugName': 'Rimonabant', 'tradeNames_string': 'Acomplia', 'drugSynonyms_string': 'Rimonabant, SR-14171, SR-141716, SR-141716A, SR141716, Zimulti', 'yearOfFirstApproval': 2006, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.672 | Q15 | When was Tosedostat approved by the FDA? | The drug Tosedostat has not been approved by the FDA. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%tosedostat%" OR LOWER(tradeNames_string) LIKE "%tosedostat%" OR LOWER(drugSynonyms_string) LIKE "%tosedostat%") AND drugIsApproved = True
LIMIT 100 | [] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.369 | Q15 | When was Eflapegrastim approved by the FDA? | The drug Eflapegrastim was first FDA approved for use in 2022. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%eflapegrastim%" OR LOWER(tradeNames_string) LIKE "%eflapegrastim%" OR LOWER(drugSynonyms_string) LIKE "%eflapegrastim%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_131', 'drugName': 'Eflapegrastim', 'tradeNames_string': 'Rolvedon', 'drugSynonyms_string': 'Eflapegrastim, Eflapegrastim-xnst, HM-10460A, HM10460A, HNK-460, HNK460, SPI-2012, SPL-2012', 'yearOfFirstApproval': 2022, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.80 | Q15 | When was Fianlimab approved by the FDA? | The drug Fianlimab has not been approved by the FDA. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%fianlimab%" OR LOWER(tradeNames_string) LIKE "%fianlimab%" OR LOWER(drugSynonyms_string) LIKE "%fianlimab%") AND drugIsApproved = True
LIMIT 100 | [] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.28 | Q15 | When was Veralipride approved by the FDA? | The drug Veralipride was first FDA approved for use in 1979. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%veralipride%" OR LOWER(tradeNames_string) LIKE "%veralipride%" OR LOWER(drugSynonyms_string) LIKE "%veralipride%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_775', 'drugName': 'Veralipride', 'tradeNames_string': 'Agreal', 'drugSynonyms_string': 'Agradil, Veralipride', 'yearOfFirstApproval': 1979, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.1438 | Q15 | When was Eribulin Mesylate approved by the FDA? | The drug Eribulin Mesylate was first FDA approved for use in 2010. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%eribulin mesylate%" OR LOWER(tradeNames_string) LIKE "%eribulin mesylate%" OR LOWER(drugSynonyms_string) LIKE "%eribulin mesylate%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_3175', 'drugName': 'Eribulin Mesylate', 'tradeNames_string': 'Halaven', 'drugSynonyms_string': 'E-7389, E7389, Eribulin (as mesylate), Eribulin mesilate, Eribulin mesylate, Eribulin monomethanesulfonate, Halaven', 'yearOfFirstApproval': 2010, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.531 | Q15 | When was Axitinib approved by the FDA? | The drug Axitinib was first FDA approved for use in 2012. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%axitinib%" OR LOWER(tradeNames_string) LIKE "%axitinib%" OR LOWER(drugSynonyms_string) LIKE "%axitinib%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_4943', 'drugName': 'Axitinib', 'tradeNames_string': 'Inlyta', 'drugSynonyms_string': 'AG-013736, AG-13736, Axitinib, NSC-757441', 'yearOfFirstApproval': 2012, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.1836 | Q15 | When was Anakinra approved by the FDA? | The drug Anakinra was first FDA approved for use in 2001. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%anakinra%" OR LOWER(tradeNames_string) LIKE "%anakinra%" OR LOWER(drugSynonyms_string) LIKE "%anakinra%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_2379', 'drugName': 'Anakinra', 'tradeNames_string': 'Antril, Kineret', 'drugSynonyms_string': 'AMG-719, Alta-2530, Alta2530, Anakinra, Interleukin-1 receptor antagonist anakinra, Osp-101', 'yearOfFirstApproval': 2001, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.56 | Q15 | When was Sklb1028 approved by the FDA? | The drug Sklb1028 has not been approved by the FDA. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%sklb1028%" OR LOWER(tradeNames_string) LIKE "%sklb1028%" OR LOWER(drugSynonyms_string) LIKE "%sklb1028%") AND drugIsApproved = True
LIMIT 100 | [] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.645 | Q15 | When was Mdx-1342 approved by the FDA? | The drug Mdx-1342 has not been approved by the FDA. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%mdx-1342%" OR LOWER(tradeNames_string) LIKE "%mdx-1342%" OR LOWER(drugSynonyms_string) LIKE "%mdx-1342%") AND drugIsApproved = True
LIMIT 100 | [] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.306 | Q15 | When was Piclozotan approved by the FDA? | The drug Piclozotan has not been approved by the FDA. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%piclozotan%" OR LOWER(tradeNames_string) LIKE "%piclozotan%" OR LOWER(drugSynonyms_string) LIKE "%piclozotan%") AND drugIsApproved = True
LIMIT 100 | [] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.725 | Q15 | When was Oprelvekin approved by the FDA? | The drug Oprelvekin was first FDA approved for use in 1997. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%oprelvekin%" OR LOWER(tradeNames_string) LIKE "%oprelvekin%" OR LOWER(drugSynonyms_string) LIKE "%oprelvekin%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_2215', 'drugName': 'Oprelvekin', 'tradeNames_string': 'Neumega', 'drugSynonyms_string': 'Interleukin-11 (2-178), Oprelvekin', 'yearOfFirstApproval': 1997, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.631 | Q15 | When was Selegiline approved by the FDA? | The drug Selegiline was first FDA approved for use in 1989. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%selegiline%" OR LOWER(tradeNames_string) LIKE "%selegiline%" OR LOWER(drugSynonyms_string) LIKE "%selegiline%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_991', 'drugName': 'Selegiline Hydrochloride', 'tradeNames_string': 'Centrapryl 10, Centrapryl 5, Eldepryl, Ensam, Selegiline hydrochloride, Stilline 10, Stilline 5, Vivapryl, Zelapar', 'drugSynonyms_string': 'L-deprenyl, NSC-759259, Selegiline hcl, Selegiline hydrochloride', 'yearOfFirstApproval': 1989, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_4707', 'drugName': 'Selegiline', 'tradeNames_string': 'Eldepryl, Emsam, Zelapar', 'drugSynonyms_string': 'Eldepryl, L-selegiline, Selegiline, Zelapar', 'yearOfFirstApproval': 1989, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.8 | Q15 | When was Pegenzileukin approved by the FDA? | The drug Pegenzileukin has not been approved by the FDA. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%pegenzileukin%" OR LOWER(tradeNames_string) LIKE "%pegenzileukin%" OR LOWER(drugSynonyms_string) LIKE "%pegenzileukin%") AND drugIsApproved = True
LIMIT 100 | [] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.810 | Q15 | When was Etretinate approved by the FDA? | The drug Etretinate was first FDA approved for use in 1986. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%etretinate%" OR LOWER(tradeNames_string) LIKE "%etretinate%" OR LOWER(drugSynonyms_string) LIKE "%etretinate%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_343', 'drugName': 'Etretinate', 'tradeNames_string': 'Tegison, Tigason', 'drugSynonyms_string': 'Acitretin related compound b, Ethyl etrinoate, Etretinate, NSC-297936, RO 10-9359, RO-10-9359, RO-109359', 'yearOfFirstApproval': 1986, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.1058 | Q15 | When was Oncolysin Cd6 approved by the FDA? | The drug Oncolysin Cd6 has not been approved by the FDA. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%oncolysin cd6%" OR LOWER(tradeNames_string) LIKE "%oncolysin cd6%" OR LOWER(drugSynonyms_string) LIKE "%oncolysin cd6%") AND drugIsApproved = True
LIMIT 100 | [] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.340 | Q15 | When was Rg-7376 approved by the FDA? | The drug Rg-7376 has not been approved by the FDA. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%rg-7376%" OR LOWER(tradeNames_string) LIKE "%rg-7376%" OR LOWER(drugSynonyms_string) LIKE "%rg-7376%") AND drugIsApproved = True
LIMIT 100 | [] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.48 | Q15 | When was Dorzolamide approved by the FDA? | The drug Dorzolamide was first FDA approved for use in 1994. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%dorzolamide%" OR LOWER(tradeNames_string) LIKE "%dorzolamide%" OR LOWER(drugSynonyms_string) LIKE "%dorzolamide%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_333', 'drugName': 'Dorzolamide', 'tradeNames_string': 'Dorzant, Trusopt', 'drugSynonyms_string': 'Dorzolamide, Dorzolamide, trans-(-)-, MK-507, Trusopt', 'yearOfFirstApproval': 1994, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_1719', 'drugName': 'Dorzolamide Hydrochloride', 'tradeNames_string': 'Cosopt Pf, Dorzolamide hydrochloride, Trusopt', 'drugSynonyms_string': 'Dorzolamide (as hydrochloride), Dorzolamide hcl, Dorzolamide hydrochloride, MK-507', 'yearOfFirstApproval': 1994, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.1481 | Q15 | When was Prilocaine Hydrochloride approved by the FDA? | The drug Prilocaine Hydrochloride was first FDA approved for use in 1965. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%prilocaine hydrochloride%" OR LOWER(tradeNames_string) LIKE "%prilocaine hydrochloride%" OR LOWER(drugSynonyms_string) LIKE "%prilocaine hydrochloride%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_281', 'drugName': 'Prilocaine Hydrochloride', 'tradeNames_string': 'Citanest, Citanest plain, Citanest plain dental, Prilocaine hydrochloride', 'drugSynonyms_string': 'ASTRA 1512, Citanest hydrochloride, L-67, NSC-758432, Prilocaine hcl, Prilocaine hydrochloride, Propitocaine hydrochloride, Xylonest', 'yearOfFirstApproval': 1965, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.109 | Q15 | When was Oxymorphone approved by the FDA? | The drug Oxymorphone was first FDA approved for use in 1959. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%oxymorphone%" OR LOWER(tradeNames_string) LIKE "%oxymorphone%" OR LOWER(drugSynonyms_string) LIKE "%oxymorphone%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_6046', 'drugName': 'Oxycodone', 'tradeNames_string': 'Oxycontin, Proladone, Xtampza er', 'drugSynonyms_string': '(-)-14-hydroxydihydrocodeinone, 14-hydroxydihydrocodeinone, Dihydrone, IDS-NO-002, N02AA05, NSC-19043, Oxicone, Oxycodone, Oxycodone cii, Oxymorphone 3-methyl ether, PF-00345439, PTI-821, Pavinal, Pti 821, Remoxy, Xtampza', 'yearOfFirstApproval': 1950, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_4591', 'drugName': 'Oxymorphone Hydrochloride', 'tradeNames_string': 'Numorphan, Opana, Opana er, Oxymorphone hydrochloride', 'drugSynonyms_string': 'Oxymorphone hcl, Oxymorphone hydrochloride', 'yearOfFirstApproval': 1959, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_3599', 'drugName': 'Oxymorphone', 'tradeNames_string': '', 'drugSynonyms_string': '14-hydroxydihydromorphinone, 7,8-dihydro-14-hydroxymorphinone, Dihydroxymorphinone, IDS-NO-003, NIH 10323, NSC-19045, Numorphan, Opana, Oxycodone hydrochloride impurity, oxymorphone-, Oxymorphone, Oxymorphone cii', 'yearOfFirstApproval': 1959, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.353 | Q15 | When was Pentoxifylline approved by the FDA? | The drug Pentoxifylline was first FDA approved for use in 1984. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%pentoxifylline%" OR LOWER(tradeNames_string) LIKE "%pentoxifylline%" OR LOWER(drugSynonyms_string) LIKE "%pentoxifylline%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_4263', 'drugName': 'Pentoxifylline', 'tradeNames_string': 'Neotren mr, Pentoxifylline, Pentoxil, Trental, Trental 100, Trental 400', 'drugSynonyms_string': 'BL 191, BL-191, C04AD03, NSC-637086, NSC-758481, Oxpentifylline, Oxypentifylline, Pentoxifylline, Pentoxiphyllin', 'yearOfFirstApproval': 1984, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_4264', 'drugName': 'Pentoxifylline', 'tradeNames_string': 'Neotren mr, Pentoxifylline, Pentoxil, Trental, Trental 100, Trental 400', 'drugSynonyms_string': 'BL 191, BL-191, C04AD03, NSC-637086, NSC-758481, Oxpentifylline, Oxypentifylline, Pentoxifylline, Pentoxiphyllin', 'yearOfFirstApproval': 1984, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.241 | Q15 | When was Moexipril Hydrochloride approved by the FDA? | The drug Moexipril Hydrochloride was first FDA approved for use in 1995. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%moexipril hydrochloride%" OR LOWER(tradeNames_string) LIKE "%moexipril hydrochloride%" OR LOWER(drugSynonyms_string) LIKE "%moexipril hydrochloride%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_517', 'drugName': 'Moexipril Hydrochloride', 'tradeNames_string': 'Moexipril hydrochloride, Perdix, Univasc', 'drugSynonyms_string': 'CI 925, CI-925, Moexipril hcl, Moexipril hydrochloride, RS-10085-197, SPM 925, SPM-925', 'yearOfFirstApproval': 1995, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.216 | Q15 | When was Anagliptin approved by the FDA? | The drug Anagliptin has not been approved by the FDA. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%anagliptin%" OR LOWER(tradeNames_string) LIKE "%anagliptin%" OR LOWER(drugSynonyms_string) LIKE "%anagliptin%") AND drugIsApproved = True
LIMIT 100 | [] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.1827 | Q15 | When was Nusinersen Sodium approved by the FDA? | The drug Nusinersen Sodium was first FDA approved for use in 2016. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%nusinersen sodium%" OR LOWER(tradeNames_string) LIKE "%nusinersen sodium%" OR LOWER(drugSynonyms_string) LIKE "%nusinersen sodium%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_6328', 'drugName': 'Nusinersen Sodium', 'tradeNames_string': 'Spinraza', 'drugSynonyms_string': 'Nusinersen sodium', 'yearOfFirstApproval': 2016, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.1138 | Q15 | When was Pentazocine Hydrochloride approved by the FDA? | The drug Pentazocine Hydrochloride was first FDA approved for use in 1969. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%pentazocine hydrochloride%" OR LOWER(tradeNames_string) LIKE "%pentazocine hydrochloride%" OR LOWER(drugSynonyms_string) LIKE "%pentazocine hydrochloride%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_3200', 'drugName': 'Pentazocine Hydrochloride', 'tradeNames_string': 'Sosegon, Talwin, Talwin 50', 'drugSynonyms_string': 'Pentazocine hcl, Pentazocine hydrochloride', 'yearOfFirstApproval': 1969, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.800 | Q15 | When was Progesterone approved by the FDA? | The drug Progesterone was first FDA approved for use in 1976. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%progesterone%" OR LOWER(tradeNames_string) LIKE "%progesterone%" OR LOWER(drugSynonyms_string) LIKE "%progesterone%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_2722', 'drugName': 'Medroxyprogesterone Acetate', 'tradeNames_string': 'Adgyn medro, Amen, Climanor, Curretab, Cycrin, Depo-progevera, Depo-provera, Depo-provera oncology, Depo-subq provera 104, Farlutal, Farlutal 100, Farlutal 200, Farlutal 250, Farlutal 500, Lunelle, Medroxyprogesterone acetate, Provera, Sayana press', 'drugSynonyms_string': 'Amen, Depot-medroxyprogesterone acetate, Farlutal inyectable, G03AC06, Medroxiprogesterone acetate, Medroxyprogesterone, Medroxyprogesterone 17-acetate, Medroxyprogesterone Acetate, Medroxyprogesterone acetate, Medroxyprogesteroni acetas, NSC-21171, NSC-26386, NSC-27408, Prempro, Provera, TV-46046', 'yearOfFirstApproval': 1959, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_4832', 'drugName': 'Hydroxyprogesterone Caproate', 'tradeNames_string': 'Delalutin, Hydroxyprogesterone caproate, Makena, Makena (autoinjector), Makena preservative free, Proluton depot', 'drugSynonyms_string': '17-ohpc, 17.alpha.-caproyloxy-p4, Depo-proluton, Hormofort, Hydroxyprogesterone, Hydroxyprogesterone caproate, Hydroxyprogesterone hexanoate, Hylutin, NSC-17592, Oxiprogesterone caproate, Pharlon, Primolut depot, Procyte depo, Proge, Syngynon, Teralutil', 'yearOfFirstApproval': 1975, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_4799', 'drugName': 'Progesterone', 'tradeNames_string': 'Crinone, Cyclogest, Endometrin, Gesterol, Lutigest, Milprosa, Prochieve, Progesta-care, Progestasert, Progesterone, Progestin, Prometrium, Regumate, Serenity for women, Syngestrone, Utrogestan', 'drugSynonyms_string': 'NSC-64377, NSC-9704, Progesterone, Progesterone, micronized, Progesteronum, U 3672', 'yearOfFirstApproval': 1976, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_184', 'drugName': 'Desoxycorticosterone Acetate', 'tradeNames_string': 'Doca, Percorten', 'drugSynonyms_string': '11-deoxycorticosterone, 11-deoxycorticosterone acetate, 21-hydroxyprogesterone, Deoxycorticosterone, Deoxycorticosterone acetate, Deoxycortone, Desoxycorticosterone, Desoxycorticosterone acetate, Desoxycortone, Desoxycortone acetate, NSC-11319, NSC-9567', 'yearOfFirstApproval': 1939, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_2024', 'drugName': 'Brexanolone', 'tradeNames_string': 'Zulresso', 'drugSynonyms_string': 'Allopregnan-3.alpha.-ol-20-one, Allopregnanolone, Allotetrahydroprogesterone, Brexanolone, SAGE-547, SGE-102', 'yearOfFirstApproval': 2019, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.1123 | Q15 | When was Insulin Zinc Susp Extended Recombinant Human approved by the FDA? | The drug Insulin Zinc Susp Extended Recombinant Human was first FDA approved for use in 1987. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%insulin zinc susp extended recombinant human%" OR LOWER(tradeNames_string) LIKE "%insulin zinc susp extended recombinant human%" OR LOWER(drugSynonyms_string) LIKE "%insulin zinc susp extended recombinant human%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_4713', 'drugName': 'Insulin Zinc Susp Extended Recombinant Human', 'tradeNames_string': 'Humulin u', 'drugSynonyms_string': 'Insulin zinc susp extended recombinant human', 'yearOfFirstApproval': 1987, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.1583 | Q15 | When was Ranibizumab approved by the FDA? | The drug Ranibizumab was first FDA approved for use in 2006. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%ranibizumab%" OR LOWER(tradeNames_string) LIKE "%ranibizumab%" OR LOWER(drugSynonyms_string) LIKE "%ranibizumab%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_2824', 'drugName': 'Ranibizumab', 'tradeNames_string': 'Lucentis', 'drugSynonyms_string': 'BCD-300, Byooviz, FAB-12 VARIANT Y0317, PF-582, Pf-582 (ranibizumab biosimilar), Pf582, QL-1205, QL1205, RG-3645, RHUFAB, Ranibizumab, Ranibizumab biosimilar pf582, Ranibizumab nuna, Ranibizumab-nuna, SB-11, SB11 (RANIBIZUMAB BIOSIMILAR), Susvimo', 'yearOfFirstApproval': 2006, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.1672 | Q15 | When was Trifluoperazine approved by the FDA? | The drug Trifluoperazine was first FDA approved for use in 1959. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%trifluoperazine%" OR LOWER(tradeNames_string) LIKE "%trifluoperazine%" OR LOWER(drugSynonyms_string) LIKE "%trifluoperazine%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_5532', 'drugName': 'Trifluoperazine Hydrochloride', 'tradeNames_string': 'Stelazine, Trifluoperazine hydrochloride', 'drugSynonyms_string': 'NSC-757369, Trifluoperazine HCl, Trifluoperazine dihydrochloride, Trifluoperazine hcl, Trifluoperazine hydrochloride, Trifluoperazine maleate', 'yearOfFirstApproval': 1959, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_5533', 'drugName': 'Trifluoperazine Hydrochloride', 'tradeNames_string': 'Stelazine, Trifluoperazine hydrochloride', 'drugSynonyms_string': 'NSC-757369, Trifluoperazine HCl, Trifluoperazine dihydrochloride, Trifluoperazine hcl, Trifluoperazine hydrochloride, Trifluoperazine maleate', 'yearOfFirstApproval': 1959, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_5534', 'drugName': 'Trifluoperazine Hydrochloride', 'tradeNames_string': 'Stelazine, Trifluoperazine hydrochloride', 'drugSynonyms_string': 'NSC-757369, Trifluoperazine HCl, Trifluoperazine dihydrochloride, Trifluoperazine hcl, Trifluoperazine hydrochloride, Trifluoperazine maleate', 'yearOfFirstApproval': 1959, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_5158', 'drugName': 'Trifluoperazine', 'tradeNames_string': 'Amylozine, Stelazine, Stelazine fte', 'drugSynonyms_string': 'Apo-trifluoperazine, Flurazine, NSC-17474, NSC-46061, RP-7623, Trifluoperazine', 'yearOfFirstApproval': 1959, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_5159', 'drugName': 'Trifluoperazine', 'tradeNames_string': 'Amylozine, Stelazine, Stelazine fte', 'drugSynonyms_string': 'Apo-trifluoperazine, Flurazine, NSC-17474, NSC-46061, RP-7623, Trifluoperazine', 'yearOfFirstApproval': 1959, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_5160', 'drugName': 'Trifluoperazine', 'tradeNames_string': 'Amylozine, Stelazine, Stelazine fte', 'drugSynonyms_string': 'Apo-trifluoperazine, Flurazine, NSC-17474, NSC-46061, RP-7623, Trifluoperazine', 'yearOfFirstApproval': 1959, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.529 | Q15 | When was Selumetinib Sulfate approved by the FDA? | The drug Selumetinib Sulfate was first FDA approved for use in 2020. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%selumetinib sulfate%" OR LOWER(tradeNames_string) LIKE "%selumetinib sulfate%" OR LOWER(drugSynonyms_string) LIKE "%selumetinib sulfate%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_3990', 'drugName': 'Selumetinib Sulfate', 'tradeNames_string': 'Koselugo', 'drugSynonyms_string': 'AZD-6244 HYD-SULFATE, AZD-6244 HYDROGEN SULFATE, AZD6244 HYD-SULFATE, AZD6244 HYDROGEN SULFATE, Azd-6244 hydrogen sulphate, Azd6244 hydrogen sulphate, Selumetinib sulfate, Selumetinib sulphate', 'yearOfFirstApproval': 2020, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.235 | Q15 | When was Resatorvid approved by the FDA? | The drug Resatorvid has not been approved by the FDA. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%resatorvid%" OR LOWER(tradeNames_string) LIKE "%resatorvid%" OR LOWER(drugSynonyms_string) LIKE "%resatorvid%") AND drugIsApproved = True
LIMIT 100 | [] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.651 | Q15 | When was Apl-501 approved by the FDA? | The drug Apl-501 has not been approved by the FDA. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%apl-501%" OR LOWER(tradeNames_string) LIKE "%apl-501%" OR LOWER(drugSynonyms_string) LIKE "%apl-501%") AND drugIsApproved = True
LIMIT 100 | [] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.1509 | Q15 | When was Cr-3465 approved by the FDA? | The drug Cr-3465 has not been approved by the FDA. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%cr-3465%" OR LOWER(tradeNames_string) LIKE "%cr-3465%" OR LOWER(drugSynonyms_string) LIKE "%cr-3465%") AND drugIsApproved = True
LIMIT 100 | [] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.539 | Q15 | When was Dextrothyroxine approved by the FDA? | The drug Dextrothyroxine was first FDA approved for use in 1967. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%dextrothyroxine%" OR LOWER(tradeNames_string) LIKE "%dextrothyroxine%" OR LOWER(drugSynonyms_string) LIKE "%dextrothyroxine%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_4368', 'drugName': 'Dextrothyroxine Sodium', 'tradeNames_string': 'Choloxin', 'drugSynonyms_string': 'Anhydrous dextrothyroxine sodium, D-thyroxine sodium salt, Dextrothyroxine sodium, Dextrothyroxine sodium anhydrous, Dextrothyroxine sodium hydrate, Monosodium d-thyroxine hydrate, Sodium dextrothyroxine', 'yearOfFirstApproval': 1967, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_4459', 'drugName': 'Dextrothyroxine', 'tradeNames_string': 'Thyroxine', 'drugSynonyms_string': 'Choloxin, D-thyroxine, Dextrothyroxine, Liotrix', 'yearOfFirstApproval': 1967, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.1753 | Q15 | When was Imgatuzumab approved by the FDA? | The drug Imgatuzumab has not been approved by the FDA. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%imgatuzumab%" OR LOWER(tradeNames_string) LIKE "%imgatuzumab%" OR LOWER(drugSynonyms_string) LIKE "%imgatuzumab%") AND drugIsApproved = True
LIMIT 100 | [] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.610 | Q15 | When was Azilsartan approved by the FDA? | The drug Azilsartan has not been approved by the FDA. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%azilsartan%" OR LOWER(tradeNames_string) LIKE "%azilsartan%" OR LOWER(drugSynonyms_string) LIKE "%azilsartan%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_5498', 'drugName': 'Azilsartan Medoxomil', 'tradeNames_string': 'Edarbi', 'drugSynonyms_string': 'AR-14, Azilsartan medoxomil, Ipreziv, TAK 491, TAK-491', 'yearOfFirstApproval': 2011, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_1209', 'drugName': 'Azilsartan Kamedoxomil', 'tradeNames_string': 'Edarbi', 'drugSynonyms_string': 'Azilsartan kamedoxomil, Azilsartan medoxomil potassium, TAK-491', 'yearOfFirstApproval': 2011, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.1780 | Q15 | When was Ertumaxomab approved by the FDA? | The drug Ertumaxomab has not been approved by the FDA. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%ertumaxomab%" OR LOWER(tradeNames_string) LIKE "%ertumaxomab%" OR LOWER(drugSynonyms_string) LIKE "%ertumaxomab%") AND drugIsApproved = True
LIMIT 100 | [] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.1083 | Q15 | When was Triamterene approved by the FDA? | The drug Triamterene was first FDA approved for use in 1964. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%triamterene%" OR LOWER(tradeNames_string) LIKE "%triamterene%" OR LOWER(drugSynonyms_string) LIKE "%triamterene%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_4230', 'drugName': 'Triamterene', 'tradeNames_string': 'Dyrenium, Dytac', 'drugSynonyms_string': 'NSC-639359, NSC-77625, SK&F 8542, SK&F-8542, SK-8542, Triamterene', 'yearOfFirstApproval': 1964, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.1407 | Q15 | When was Ziconotide Acetate approved by the FDA? | The drug Ziconotide Acetate was first FDA approved for use in 2004. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%ziconotide acetate%" OR LOWER(tradeNames_string) LIKE "%ziconotide acetate%" OR LOWER(drugSynonyms_string) LIKE "%ziconotide acetate%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_4779', 'drugName': 'Ziconotide Acetate', 'tradeNames_string': 'Prialt', 'drugSynonyms_string': 'Ziconotide acetate', 'yearOfFirstApproval': 2004, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.62 | Q15 | When was Pancuronium approved by the FDA? | The drug Pancuronium was first FDA approved for use in 1972. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%pancuronium%" OR LOWER(tradeNames_string) LIKE "%pancuronium%" OR LOWER(drugSynonyms_string) LIKE "%pancuronium%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_4096', 'drugName': 'Pancuronium', 'tradeNames_string': '', 'drugSynonyms_string': 'Pancuronium, Pavulon', 'yearOfFirstApproval': 1972, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_6111', 'drugName': 'Pancuronium Bromide', 'tradeNames_string': 'Mioblock, Pancuronium bromide, Pavulon', 'drugSynonyms_string': 'Bromurex, Mioblock, NSC-293162, ORG NA 97, ORG-NA 97, ORG-NA-97, Pancuronium bromide', 'yearOfFirstApproval': 1972, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_4193', 'drugName': 'Vecuronium Bromide', 'tradeNames_string': 'Musculax, Norcuron, Vecuronium bromide', 'drugSynonyms_string': 'NSC-759184, ORG NC 45, ORG-NC 45, Pancuronium bromide impurity, vecuronium bromide -, Vecuronium bromide', 'yearOfFirstApproval': 1984, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.1643 | Q15 | When was Alteplase approved by the FDA? | The drug Alteplase was first FDA approved for use in 1996. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%alteplase%" OR LOWER(tradeNames_string) LIKE "%alteplase%" OR LOWER(drugSynonyms_string) LIKE "%alteplase%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_2954', 'drugName': 'Alteplase', 'tradeNames_string': 'Actilyse, Actilyse cathflo, Activase, Cathflo activase', 'drugSynonyms_string': 'Alteplase, Alteplase (genetical recombination), Alteplase for injection, Alteplase, recombinant, Alteplase,recombinant, Ec 3.4.21.68, RT-PA, Tissue plasminogen activator alteplase', 'yearOfFirstApproval': 1996, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.95 | Q15 | When was Linerixibat approved by the FDA? | The drug Linerixibat has not been approved by the FDA. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%linerixibat%" OR LOWER(tradeNames_string) LIKE "%linerixibat%" OR LOWER(drugSynonyms_string) LIKE "%linerixibat%") AND drugIsApproved = True
LIMIT 100 | [] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.673 | Q15 | When was Umbralisib approved by the FDA? | The drug Umbralisib was first FDA approved for use in 2021. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%umbralisib%" OR LOWER(tradeNames_string) LIKE "%umbralisib%" OR LOWER(drugSynonyms_string) LIKE "%umbralisib%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_3011', 'drugName': 'Umbralisib Tosylate', 'tradeNames_string': 'Ukoniq', 'drugSynonyms_string': 'RP-5307, TGR-1202, TGR-1202 (4-METHYLBENZENESULFONATE), Tgr-1202, Umbralisib tosylate', 'yearOfFirstApproval': 2021, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_3012', 'drugName': 'Umbralisib Tosylate', 'tradeNames_string': 'Ukoniq', 'drugSynonyms_string': 'RP-5307, TGR-1202, TGR-1202 (4-METHYLBENZENESULFONATE), Tgr-1202, Umbralisib tosylate', 'yearOfFirstApproval': 2021, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_3013', 'drugName': 'Umbralisib Tosylate', 'tradeNames_string': 'Ukoniq', 'drugSynonyms_string': 'RP-5307, TGR-1202, TGR-1202 (4-METHYLBENZENESULFONATE), Tgr-1202, Umbralisib tosylate', 'yearOfFirstApproval': 2021, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_5647', 'drugName': 'Umbralisib', 'tradeNames_string': '', 'drugSynonyms_string': 'RP-5264, RP5264, TGR-1202 FREE BASE, TGR-1202 base, Tgr 1202, Umbralisib', 'yearOfFirstApproval': 2021, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_5648', 'drugName': 'Umbralisib', 'tradeNames_string': '', 'drugSynonyms_string': 'RP-5264, RP5264, TGR-1202 FREE BASE, TGR-1202 base, Tgr 1202, Umbralisib', 'yearOfFirstApproval': 2021, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_5649', 'drugName': 'Umbralisib', 'tradeNames_string': '', 'drugSynonyms_string': 'RP-5264, RP5264, TGR-1202 FREE BASE, TGR-1202 base, Tgr 1202, Umbralisib', 'yearOfFirstApproval': 2021, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.284 | Q15 | When was Indomethacin Sodium approved by the FDA? | The drug Indomethacin Sodium was first FDA approved for use in 1985. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%indomethacin sodium%" OR LOWER(tradeNames_string) LIKE "%indomethacin sodium%" OR LOWER(drugSynonyms_string) LIKE "%indomethacin sodium%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_4252', 'drugName': 'Indomethacin Sodium', 'tradeNames_string': 'Indocin, Indomethacin sodium', 'drugSynonyms_string': 'Indometacin sodium, Indometacin sodium hydrate, Indometacin sodium trihydrate, Indomethacin sodium, Indomethacin sodium anhydrous, Indomethacin sodium salt trihydrate, Indomethacin sodium trihydrate, Sodium indomethacin, Sodium indomethacin trihydrate', 'yearOfFirstApproval': 1985, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.1796 | Q15 | When was Isoetharine Mesylate approved by the FDA? | The drug Isoetharine Mesylate was first FDA approved for use in 1984. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%isoetharine mesylate%" OR LOWER(tradeNames_string) LIKE "%isoetharine mesylate%" OR LOWER(drugSynonyms_string) LIKE "%isoetharine mesylate%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_1915', 'drugName': 'Isoetharine Mesylate', 'tradeNames_string': 'Bronchilator, Bronkometer, Isoetharine mesylate', 'drugSynonyms_string': 'Isoetarine mesilate, Isoetharine mesilate, Isoetharine mesylate, NSC-759286', 'yearOfFirstApproval': 1984, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.364 | Q15 | When was Peginterferon Alfa-2B approved by the FDA? | The drug Peginterferon Alfa-2B was first FDA approved for use in 2001. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%peginterferon alfa-2b%" OR LOWER(tradeNames_string) LIKE "%peginterferon alfa-2b%" OR LOWER(drugSynonyms_string) LIKE "%peginterferon alfa-2b%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_2953', 'drugName': 'Peginterferon Alfa-2B', 'tradeNames_string': 'Peg-Intron, Pegintron', 'drugSynonyms_string': 'Peg-interferon alfa-2b, Pegifn alfa-2b, Peginterferon alfa-2b, Peginterferon-alfa-2b, Pegylated interferon alpha 2b, Sylatron', 'yearOfFirstApproval': 2001, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_5976', 'drugName': 'Ropeginterferon Alfa-2B', 'tradeNames_string': 'Besremi', 'drugSynonyms_string': 'Aop2014, Besremi, P-1101, P1101, Ropeginterferon alfa-2b, Ropeginterferon alfa-2b njft, Ropeginterferon alfa-2b-njft', 'yearOfFirstApproval': 2021, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.1468 | Q15 | When was Saxagliptin approved by the FDA? | The drug Saxagliptin was first FDA approved for use in 2009. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%saxagliptin%" OR LOWER(tradeNames_string) LIKE "%saxagliptin%" OR LOWER(drugSynonyms_string) LIKE "%saxagliptin%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_6010', 'drugName': 'Saxagliptin', 'tradeNames_string': '', 'drugSynonyms_string': 'BMS-477118, BMS-477118-11, Saxagliptin', 'yearOfFirstApproval': 2009, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_2239', 'drugName': 'Saxagliptin Hydrochloride', 'tradeNames_string': 'Onglyza', 'drugSynonyms_string': 'Saxagliptin HCl, Saxagliptin hcl, Saxagliptin hydrochloride', 'yearOfFirstApproval': 2009, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.1169 | Q15 | When was Agatolimod Sodium approved by the FDA? | The drug Agatolimod Sodium has not been approved by the FDA. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%agatolimod sodium%" OR LOWER(tradeNames_string) LIKE "%agatolimod sodium%" OR LOWER(drugSynonyms_string) LIKE "%agatolimod sodium%") AND drugIsApproved = True
LIMIT 100 | [] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.854 | Q15 | When was Azatadine approved by the FDA? | The drug Azatadine was first FDA approved for use in 1977. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%azatadine%" OR LOWER(tradeNames_string) LIKE "%azatadine%" OR LOWER(drugSynonyms_string) LIKE "%azatadine%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_603', 'drugName': 'Azatadine', 'tradeNames_string': '', 'drugSynonyms_string': 'Azatadine, Optimine, Trinalin', 'yearOfFirstApproval': 1977, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_4332', 'drugName': 'Azatadine Maleate', 'tradeNames_string': 'Lergocil, Optimine', 'drugSynonyms_string': 'Azatadine dimaleate, Azatadine maleate, NSC-759874, SCH 10649, SCH-10649', 'yearOfFirstApproval': 1977, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.1379 | Q15 | When was Pevonedistat approved by the FDA? | The drug Pevonedistat has not been approved by the FDA. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%pevonedistat%" OR LOWER(tradeNames_string) LIKE "%pevonedistat%" OR LOWER(drugSynonyms_string) LIKE "%pevonedistat%") AND drugIsApproved = True
LIMIT 100 | [] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.113 | Q15 | When was Ofatumumab approved by the FDA? | The drug Ofatumumab was first FDA approved for use in 2009. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%ofatumumab%" OR LOWER(tradeNames_string) LIKE "%ofatumumab%" OR LOWER(drugSynonyms_string) LIKE "%ofatumumab%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_3424', 'drugName': 'Ofatumumab', 'tradeNames_string': 'Arzerra', 'drugSynonyms_string': '2F2, GSK-1841157, GSK1841157, HUMAX-CD20, HUMAX-CD20 2F2, HUMAX-CD20, 2F2, HUMAX-CD20-2F2, Ofatumumab', 'yearOfFirstApproval': 2009, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.43 | Q15 | When was Gefitinib approved by the FDA? | The drug Gefitinib was first FDA approved for use in 2003. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%gefitinib%" OR LOWER(tradeNames_string) LIKE "%gefitinib%" OR LOWER(drugSynonyms_string) LIKE "%gefitinib%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_4972', 'drugName': 'Gefitinib', 'tradeNames_string': 'Iressa', 'drugSynonyms_string': 'Gefitinib, Iressa, NSC-759856, ZD-1839, ZD1839', 'yearOfFirstApproval': 2003, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.128 | Q15 | When was Talbutal approved by the FDA? | The drug Talbutal was first FDA approved for use in 1982. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%talbutal%" OR LOWER(tradeNames_string) LIKE "%talbutal%" OR LOWER(drugSynonyms_string) LIKE "%talbutal%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_2623', 'drugName': 'Talbutal', 'tradeNames_string': 'Lotusate', 'drugSynonyms_string': 'Talbutal', 'yearOfFirstApproval': 1982, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.207 | Q15 | When was Siltuximab approved by the FDA? | The drug Siltuximab was first FDA approved for use in 2014. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%siltuximab%" OR LOWER(tradeNames_string) LIKE "%siltuximab%" OR LOWER(drugSynonyms_string) LIKE "%siltuximab%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_2074', 'drugName': 'Siltuximab', 'tradeNames_string': 'Sylvant', 'drugSynonyms_string': 'CLLB8, CNTO-328, Siltuximab', 'yearOfFirstApproval': 2014, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.53 | Q15 | When was Adalimumab approved by the FDA? | The drug Adalimumab was first FDA approved for use in 2002. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%adalimumab%" OR LOWER(tradeNames_string) LIKE "%adalimumab%" OR LOWER(drugSynonyms_string) LIKE "%adalimumab%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_3802', 'drugName': 'Adalimumab', 'tradeNames_string': 'Humira', 'drugSynonyms_string': 'AVT-02, Abp-501, Abrilada, Adalimumab, Adalimumab (genetical recombination), Adalimumab (humira), Adalimumab adaz, Adalimumab adbm, Adalimumab afzb, Adalimumab aqvh, Adalimumab atto, Adalimumab beta, Adalimumab biosimilar (alvotech), Adalimumab biosimilar (avt02), Adalimumab biosimilar (celltrion), Adalimumab biosimilar (ct-p17), Adalimumab biosimilar (fkb-327), Adalimumab biosimilar (zrc-3197), Adalimumab bwwd, Adalimumab-adaz, Adalimumab-adbm, Adalimumab-afzb, Adalimumab-aqvh, Adalimumab-atto, Adalimumab-bwwd, Adalimumab-fkjp, Amjevita, Avt02, BI695501, Bcd-057, Bi 695501, Bi-695501, CT-P17, Chs-1420, Cyltezo, D2E7, Exemptia, FKB-327, FKB327, GP2017, Gp-2017, HLX-03, HLX03, Hadlima, Hulio, Hyrimoz, LU-200134, LU200134, M-923, M923, MSB-11022, MSB11022, Ons-3010, Trudexa, Yusimry, ZRC-3197, ZRC3197', 'yearOfFirstApproval': 2002, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.551 | Q15 | When was Nandrolone Phenpropionate approved by the FDA? | The drug Nandrolone Phenpropionate was first FDA approved for use in 1959. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%nandrolone phenpropionate%" OR LOWER(tradeNames_string) LIKE "%nandrolone phenpropionate%" OR LOWER(drugSynonyms_string) LIKE "%nandrolone phenpropionate%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_4237', 'drugName': 'Nandrolone Phenpropionate', 'tradeNames_string': 'Durabolin, Nandrolone phenpropionate', 'drugSynonyms_string': 'Nandrolone phenpropionate, Nandrolone phenylpropionate, Norandrostenolone phenylpropionate, Nortestosterone furanpropionate, Nortestosterone phenylpropionate', 'yearOfFirstApproval': 1959, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.71 | Q15 | When was Trihexyphenidyl approved by the FDA? | The drug Trihexyphenidyl was first FDA approved for use in 1949. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%trihexyphenidyl%" OR LOWER(tradeNames_string) LIKE "%trihexyphenidyl%" OR LOWER(drugSynonyms_string) LIKE "%trihexyphenidyl%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_6217', 'drugName': 'Trihexyphenidyl', 'tradeNames_string': '', 'drugSynonyms_string': 'Apo-trihex, NSC-12268, Trihexyphenidyl', 'yearOfFirstApproval': 1949, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_6050', 'drugName': 'Trihexyphenidyl Hydrochloride', 'tradeNames_string': 'Agitane, Artane, Bentex, Broflex, Tremin, Trihexyphenidyl hydrochloride', 'drugSynonyms_string': 'Aparkane, Benzhexol, Benzhexol hydrochloride, Cyclodol, Cyclodolum, NSC-757357, Parcopane, Romparkin, Sedrina, Trihexyphenidyl HCl, Trihexyphenidyl hcl, Trihexyphenidyl hydrochloride, Trihexyphenidyli hydrochloridum, Triphedinon', 'yearOfFirstApproval': 1949, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.1816 | Q15 | When was Rituximab approved by the FDA? | The drug Rituximab was first FDA approved for use in 1997. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%rituximab%" OR LOWER(tradeNames_string) LIKE "%rituximab%" OR LOWER(drugSynonyms_string) LIKE "%rituximab%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_4195', 'drugName': 'Rituximab', 'tradeNames_string': 'Mabthera, Mabthera rituxan, Rituxan', 'drugSynonyms_string': 'ABP-798, ABP798, BI695500, Bi 695500, Bi-695500, Blitzima, CT-P10, Gp2013, HS-006, HS-006 (RITUXIMAB BIOSIMILAR), HS006, IDEC-102, IDEC-C2B8, Mk-8808, Pf-05280586, R-105 IDEC-102, RG-105, RHCACD20MA, Riabni, Ritemvia, Rituximab, Rituximab (genetical recombination), Rituximab abbs, Rituximab arrx, Rituximab biosimilar - celltrion, Rituximab biosimilar -merck, Rituximab pvvr, Rituximab-abbs, Rituximab-arrx, Rituximab-boehringer ingelheim, Rituximab-ct-p10, Rituximab-pfizer, Rituximab-pvvr, Ruxience, SAIT-101, SAIT101, Truxima, Tuxella, Usp mab 001, monoclonal igg1, Zuberitamab', 'yearOfFirstApproval': 1997, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.1745 | Q15 | When was Morphine Sulfate approved by the FDA? | The drug Morphine Sulfate was first FDA approved for use in 1984. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%morphine sulfate%" OR LOWER(tradeNames_string) LIKE "%morphine sulfate%" OR LOWER(drugSynonyms_string) LIKE "%morphine sulfate%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_3650', 'drugName': 'Morphine Sulfate', 'tradeNames_string': 'Arymo er, Astramorph pf, Avinza, Depodur, Duramorph, Duramorph pf, Duromorph, Filnarine sr, Infumorph, Kadian, Moraxen, Morcap sr, Morphabond, Morphabond er, Morphgesic sr, Morphine sulfate, Morphine sulfate (autoinjector), Ms contin, Mst continus, Oramorph, Oramorph sr, Oramorph udv, Rhotard, Sevredol, Srm-rhotard, Zomorph', 'drugSynonyms_string': 'Arymo, Astramorph, Dolcontin, Kapanol, Morcap, Morphine sulfate, Morphine sulfate anhydrous, Morphine sulfate cii, Morphine sulfate hydrate, Morphine sulfate pentahydrate, Morphine sulfate,anhydrous, Morphine sulphate, Morphine sulphate anhydrous, Morphine sulphate pentahydrate, Morphini sulfas, Moscontin, NSC-11441', 'yearOfFirstApproval': 1984, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.186 | Q15 | When was Mecasermin approved by the FDA? | The drug Mecasermin was first FDA approved for use in 2005. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%mecasermin%" OR LOWER(tradeNames_string) LIKE "%mecasermin%" OR LOWER(drugSynonyms_string) LIKE "%mecasermin%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_672', 'drugName': 'Mecasermin Rinfabate', 'tradeNames_string': 'Iplex, Somatokine', 'drugSynonyms_string': 'Mecasermin Rinfabate Recombinant, Mecasermin rinfabate, Mecasermin rinfabate recombinant, RHIGF-I/RHIGFBP-3', 'yearOfFirstApproval': 2005, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_2750', 'drugName': 'Mecasermin', 'tradeNames_string': 'Increlex, Myotrophin', 'drugSynonyms_string': 'CEP-151, Cg-gf2, Cg-igf-1, Igf-1-ec, Igf-1ec, Insulin-like growth factor 1, Insulin-like growth factor i, Mecasermin, Mecasermin recombinant, Mechano growth factor, Pv-802, Pv802, Rh-oligopeptide-2, Sh-oligopeptide-2, Somatomedin c, Somatomedin c, human, Vexxon-igf-1', 'yearOfFirstApproval': 2005, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.140 | Q15 | When was Ongericimab approved by the FDA? | The drug Ongericimab has not been approved by the FDA. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%ongericimab%" OR LOWER(tradeNames_string) LIKE "%ongericimab%" OR LOWER(drugSynonyms_string) LIKE "%ongericimab%") AND drugIsApproved = True
LIMIT 100 | [] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.907 | Q15 | When was Mirikizumab approved by the FDA? | The drug Mirikizumab has not been approved by the FDA. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%mirikizumab%" OR LOWER(tradeNames_string) LIKE "%mirikizumab%" OR LOWER(drugSynonyms_string) LIKE "%mirikizumab%") AND drugIsApproved = True
LIMIT 100 | [] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.803 | Q15 | When was Desirudin approved by the FDA? | The drug Desirudin was first FDA approved for use in 2003. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%desirudin%" OR LOWER(tradeNames_string) LIKE "%desirudin%" OR LOWER(drugSynonyms_string) LIKE "%desirudin%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_2822', 'drugName': 'Desirudin', 'tradeNames_string': 'Iprivask', 'drugSynonyms_string': '63-desulfohirudin, 63-desulfohirudin (recombinant), CGP 39393, CGP-39393, Desirudin, Desirudin recombinant, Hirudin desirudin, Revasc', 'yearOfFirstApproval': 2003, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.135 | Q15 | When was Ethosuximide approved by the FDA? | The drug Ethosuximide was first FDA approved for use in 1960. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%ethosuximide%" OR LOWER(tradeNames_string) LIKE "%ethosuximide%" OR LOWER(drugSynonyms_string) LIKE "%ethosuximide%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_4742', 'drugName': 'Ethosuximide', 'tradeNames_string': 'Emeside, Ethosuximide, Suxinutin, Zarontin', 'drugSynonyms_string': 'CI-366, CN-10,395, CN-10395, Ethosuximide, Ethosuximidum, NSC-64013, PM-671, Pyknolepsinum', 'yearOfFirstApproval': 1960, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.83 | Q15 | When was Maraviroc approved by the FDA? | The drug Maraviroc was first FDA approved for use in 2007. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%maraviroc%" OR LOWER(tradeNames_string) LIKE "%maraviroc%" OR LOWER(drugSynonyms_string) LIKE "%maraviroc%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_3537', 'drugName': 'Maraviroc', 'tradeNames_string': 'Celsentri, Selzentry', 'drugSynonyms_string': 'Maraviroc, Rel-Maraviroc, UK-427857, Uk-427,857', 'yearOfFirstApproval': 2007, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.1541 | Q15 | When was Moricizine approved by the FDA? | The drug Moricizine was first FDA approved for use in 1990. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%moricizine%" OR LOWER(tradeNames_string) LIKE "%moricizine%" OR LOWER(drugSynonyms_string) LIKE "%moricizine%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_4424', 'drugName': 'Moricizine', 'tradeNames_string': 'Ethmozine', 'drugSynonyms_string': 'EN-313, EN-313 FREE BASE, Ethmozine, Moracizine, Moricizine', 'yearOfFirstApproval': 1990, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_2214', 'drugName': 'Moricizine Hydrochloride', 'tradeNames_string': 'Ethmozine', 'drugSynonyms_string': 'Moracizine hydrochloride, Moricizine hcl, Moricizine hydrochloride', 'yearOfFirstApproval': 1990, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.547 | Q15 | When was Isoflurane approved by the FDA? | The drug Isoflurane was first FDA approved for use in 1979. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%isoflurane%" OR LOWER(tradeNames_string) LIKE "%isoflurane%" OR LOWER(drugSynonyms_string) LIKE "%isoflurane%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_5594', 'drugName': 'Isoflurane', 'tradeNames_string': 'Aerrane, Forane, Isoflurane', 'drugSynonyms_string': 'COMPOUND 469, COMPOUND-469, Isoflurane', 'yearOfFirstApproval': 1979, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_5595', 'drugName': 'Isoflurane', 'tradeNames_string': 'Aerrane, Forane, Isoflurane', 'drugSynonyms_string': 'COMPOUND 469, COMPOUND-469, Isoflurane', 'yearOfFirstApproval': 1979, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_5596', 'drugName': 'Isoflurane', 'tradeNames_string': 'Aerrane, Forane, Isoflurane', 'drugSynonyms_string': 'COMPOUND 469, COMPOUND-469, Isoflurane', 'yearOfFirstApproval': 1979, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_5597', 'drugName': 'Isoflurane', 'tradeNames_string': 'Aerrane, Forane, Isoflurane', 'drugSynonyms_string': 'COMPOUND 469, COMPOUND-469, Isoflurane', 'yearOfFirstApproval': 1979, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_5598', 'drugName': 'Isoflurane', 'tradeNames_string': 'Aerrane, Forane, Isoflurane', 'drugSynonyms_string': 'COMPOUND 469, COMPOUND-469, Isoflurane', 'yearOfFirstApproval': 1979, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_5599', 'drugName': 'Isoflurane', 'tradeNames_string': 'Aerrane, Forane, Isoflurane', 'drugSynonyms_string': 'COMPOUND 469, COMPOUND-469, Isoflurane', 'yearOfFirstApproval': 1979, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_5600', 'drugName': 'Isoflurane', 'tradeNames_string': 'Aerrane, Forane, Isoflurane', 'drugSynonyms_string': 'COMPOUND 469, COMPOUND-469, Isoflurane', 'yearOfFirstApproval': 1979, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.1596 | Q15 | When was Vardenafil approved by the FDA? | The drug Vardenafil was first FDA approved for use in 2003. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%vardenafil%" OR LOWER(tradeNames_string) LIKE "%vardenafil%" OR LOWER(drugSynonyms_string) LIKE "%vardenafil%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_2264', 'drugName': 'Vardenafil', 'tradeNames_string': 'Levitra', 'drugSynonyms_string': 'BAY-389456, BAY38-9456, Vardenafil, Vivanza', 'yearOfFirstApproval': 2003, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_4542', 'drugName': 'Vardenafil Hydrochloride', 'tradeNames_string': 'Levitra, Staxyn, Vardenafil hydrochloride', 'drugSynonyms_string': 'BAY 38-9456, BAY-38-9456, Nuviva, Vardenafil hcl, Vardenafil hydrochloride, Vardenafil hydrochloride anhydrous, Vardenafil hydrochloride hydrate, Vardenafil hydrochloride trihydrate, Vardenafil monohydrochloride', 'yearOfFirstApproval': 2003, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.992 | Q15 | When was Figopitant approved by the FDA? | The drug Figopitant has not been approved by the FDA. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%figopitant%" OR LOWER(tradeNames_string) LIKE "%figopitant%" OR LOWER(drugSynonyms_string) LIKE "%figopitant%") AND drugIsApproved = True
LIMIT 100 | [] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.168 | Q15 | When was Metaproterenol approved by the FDA? | The drug Metaproterenol was first FDA approved for use in 1973. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%metaproterenol%" OR LOWER(tradeNames_string) LIKE "%metaproterenol%" OR LOWER(drugSynonyms_string) LIKE "%metaproterenol%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_1717', 'drugName': 'Metaproterenol', 'tradeNames_string': '', 'drugSynonyms_string': 'Metaproterenol, Orciprenaline', 'yearOfFirstApproval': 1973, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_5266', 'drugName': 'Metaproterenol Sulfate', 'tradeNames_string': 'Alupent, Alupent obstetric, Metaproterenol sulfate, Prometa', 'drugSynonyms_string': 'Metaproterenol sulfate, Metaproterenol sulphate, Orciprenaline sulfate, Orciprenaline sulphate, TH-152', 'yearOfFirstApproval': 1973, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.251 | Q15 | When was Chlorpheniramine approved by the FDA? | The drug Chlorpheniramine was first FDA approved for use in 1950. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%chlorpheniramine%" OR LOWER(tradeNames_string) LIKE "%chlorpheniramine%" OR LOWER(drugSynonyms_string) LIKE "%chlorpheniramine%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_4827', 'drugName': 'Chlorpheniramine', 'tradeNames_string': '', 'drugSynonyms_string': 'Antagonate, Chlor-Trimeton, Chlorphenamine, Chlorpheniramine, Isoclor, Kloromin, Phenetron, Teldrin', 'yearOfFirstApproval': 1950, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_221', 'drugName': 'Chlorpheniramine Maleate', 'tradeNames_string': 'Allercalm allergy relief, Allerief, Alunex, Antagonate, Calimal, Chlor-trimeton, Chlorphenamine, Chlorpheniramine maleate, Efidac 24 chlorpheniramine maleate, Hayleve, Kloromin, Phenetron, Piriject, Piriton, Piriton allergy, Pyridamal 100, Rhino-syrup allergy, Rimarin, Teldrin', 'drugSynonyms_string': '(+)-Chlorpheniramine Maleate, Chlorphenamine hydrogen maleate, Chlorphenamine maleate, Chlorphenamini hydrogenomaleas, Chlorpheniramine Maleate, Chlorpheniramine maleate, Chlorprophenpyridamine maleate, Efidac, Histaspan, NSC-756684, Neorestamin, Pyridamal, Synistamin', 'yearOfFirstApproval': 1950, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_3635', 'drugName': 'Dexchlorpheniramine', 'tradeNames_string': '', 'drugSynonyms_string': 'Chlorphenamine, (s)-, Chlorpheniramine d-form, Chlorpheniramine, (s)-, Chlorpheniramine, d-, Dapriton, Dexchlorpheniramine', 'yearOfFirstApproval': 1981, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_6213', 'drugName': 'Dexchlorpheniramine Maleate', 'tradeNames_string': 'Dexchlorpheniramine maleate, Mylaramine, Polaramine', 'drugSynonyms_string': 'Chlorpheniramine d-form maleate, Chlorpheniramine maleate, (s)-, D-chlorpheniramine maleate, Dexchlorpheniramine maleate, NSC-759156', 'yearOfFirstApproval': 1981, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_706', 'drugName': 'Chlorpheniramine Polistirex', 'tradeNames_string': '', 'drugSynonyms_string': 'Chlorpheniramine polistirex', 'yearOfFirstApproval': 1984, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.452 | Q15 | When was Valrubicin approved by the FDA? | The drug Valrubicin was first FDA approved for use in 1998. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%valrubicin%" OR LOWER(tradeNames_string) LIKE "%valrubicin%" OR LOWER(drugSynonyms_string) LIKE "%valrubicin%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_484', 'drugName': 'Doxorubicin', 'tradeNames_string': 'Adriblastina', 'drugSynonyms_string': 'Adriablastin, Adriamycin, Doxil, Doxorubicin, Epirubicin hydrochloride impurity, doxorubicin-, Hydroxydaunorubicin, NSC-123127, NSC-759155, Rubex, Valrubicin impurity, doxorubicin', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_881', 'drugName': 'Daunorubicin', 'tradeNames_string': 'Daunoxome', 'drugSynonyms_string': 'Cerubidine, Daunomycin, Daunorubicin, Daunoxome, Epirubicin hydrochloride impurity, daunorubicin-, FI 6339, FI-6339, NSC-83142, RP 13057, RP-13057, Valrubicin impurity, daunorubicin', 'yearOfFirstApproval': 1979, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_6176', 'drugName': 'Valrubicin', 'tradeNames_string': 'Valstar, Valstar preservative free', 'drugSynonyms_string': 'AD 32, AD-32, NSC-246131, Valrubicin', 'yearOfFirstApproval': 1998, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Q15.1148 | Q15 | When was Procyclidine Hydrochloride approved by the FDA? | The drug Procyclidine Hydrochloride was first FDA approved for use in 1955. | SELECT DISTINCT UUID, drugName, tradeNames_string, drugSynonyms_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%procyclidine hydrochloride%" OR LOWER(tradeNames_string) LIKE "%procyclidine hydrochloride%" OR LOWER(drugSynonyms_string) LIKE "%procyclidine hydrochloride%") AND drugIsApproved = True
LIMIT 100 | [{'UUID': 'DrugGeneTargets_v2_4919', 'drugName': 'Procyclidine Hydrochloride', 'tradeNames_string': 'Arpicolin, Kemadrin, Muscinil', 'drugSynonyms_string': 'NSC-757293, Procyclidine HCl, Procyclidine hcl, Procyclidine hydrochloride', 'yearOfFirstApproval': 1955, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | refined | Distinct, Similarity Search, Multi-Filter | Approval Status |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.